Presentaties door Dr. Doris Cools

  • Clinical Results, contrast sensitivity and wavefront aberrations comparing the Pharmacia Tecnis Z9000 and the Bausch and Lomb Akreos Adapt IOLS

    Cools D., Vryghem J.
    Opthalmologica Belgica, November 2003, Brussels;

  • Isoluminant colour visual evoked potentials in nomal and colour-deficient subjects

    Cools D., Spileers W., Eneman B., Maris K., Van Malderen L.
    Opthalmologica Belica, November 2001, Brussels

  • Preliminary results of FRO project 2000: The prognostic value of chromosomal abnormalities in primary uveal melanoma.

    Cools D., Van Ginderdeuren R. Debiec-Rychter M., Spileers W.
    Opthalmologica Belgica, November 2001, Brussels

  • The clinical use of multifocal ERG in multiple ocular pathologies Preliminary results of FRO project 1999: the prognostic value of chromosomal abnormalities in primary uveal melnoma: a molecular cytogenetic study on biopsies and needle aspiration biopsies

    Cools D., Eneman B., Spileers W.
    Opthalmologica Belgica, December 2000, Brussels
     

  • Chromosomal abnormalities in uveal melanoma: A retrospective and prospective study on frozen and fresh tissue.

    Cools D., Van Ginderdeuren R., Debiec-Rychter M., Spileers W.
    EVER, European Association for Vision and Eye Research: OOG-Group-meeting, October 2000, Palma

  • The prognostic value of chromosomal abnormalities in primary uveal melanoma: a molecular cytogenetic prospective study on fresh biopsies and retrospective study on frozen and paraffin sections.

    Cools D., Van Ginderdeuren R., Debiec-Rychter M., Spileers W.
    EVER, European Association for Vision and Eye Research: Joint meeting FRO - Belgian Fund for Research in Opthalmology, October 2000, Palma

  • The prognostic value of chromosomal abnormalities in primary uveal melanoma: a molecular cytogenetic study on biopsies and needle aspiration biopsies

    Cools D., Van Ginderdeuren R. Debiec-Rychter M., Spileers W.
    EVER 1999, European Association for Vision and Eye Research Joint Meeting FRO - Belgian Fund for Research in Opthalmology, October 1999, Palma